1
Abstracts 247 59 IN SITU HYBRIDIZATION WITH A CHROMOSOME 1 SPECIFIC DNA PROBE ON INTERPHASE NUCLEI FROM PROSTATE CANCER CELLS. Josee J.K0nig, Sandra de Jong, Anne Hagemeijer*, Hans Romijn and Fritz H.SchrOder. Depts. of Urology and Genetics*, Erasmus University Rotterdam, The Netherlands. With flow cytometry half of the prostate cancers show, apart from diploid cells, considerable populations of tetraploid and/or aneuploid cells. With collagenase treatment -which is a widely used method to obtain cell suspensions from solid tumors- nearly half of the nondiploid cells is destroyed, as was shown by us earlier. When the karyotype of these same tumors was investigated, nearly all tumors were seemingly diploid with occasional nonclonal aberrations. We used detection of numerical aberrations of chromosome 1 in interphase nuclei by in situ hybridization (ISH) with the SAT III probe PUC 1.77 for further investigation of this problem. ISH was performed on nuclei obtained before and after collagenase treatment and after tissue culture and the results were compared. ISH and FCM results were congruent in showing a decline of nondiploid cells after collagenase treatment. Two tumors showed high percentages of nondiploid cells (23% and 59% ) in fresh preparations which had declined to 12% and 9% respectively after tissue culture. Moreover, in both tumors all metaphases seemed normal diploid. We think this result is a clear indication that selection in favor of normal diploid cells can occur in short term tissue culture of prostate epithelium. More tumors need however be investigated in this way to draw a definite conclusion. This study was supported by a grant of the Netherlands Cancer Foundation. 60 COMBINED CYTOGENETIC AND IMMUNCYTOCHEMICAL STUDY ON PROSTATE CANCER B Wullich I, T Lindenmeir {, G. Seitz 2, Th. Zwergel 3, G Unteregger I qnst. f~r Humangenetik. Univ. des Saarlandes. D-6650 H0mburg Saar 2Inst. fiir Pathologie, Univ. des Saarlandes, D-6650 Homburg/Saar alrrologische Klinik, Univ. des Saarlandes, D-6650 Homburg/Saar Specific chromosomal changes have been discovered in several human solid rumors and have been found to be useful tools in the diagnosis, prognosis, and classification of these diseases. However, only few cytogenetic data are available on prostatic cancer, and specific chromosomal changes associated with this kind of tumor have yet been found. We started to perform cytogenetic analyses on cell cultures of primary prostatic adenocarcinomas and metastatic lesions, lrp to no~, long-term cultures were successfully established from twelve tumors by applying enzymatic digestion or tissue explant of the resected tumor material. Cylogenetic characterization of hitherto three tumors revealed loss of the Y chromosome as single clonal abnormality in two tumors. One tumor showed normal karyotype. Conclusions about the significance of loss of the Y chromosome in development and/or progression of metastatic cancer seem premature. Remarkably, the two tumors characterized by loss of the Y chromosome were histopathologically diagnosed as moderately differentiated and undifferentiated adenocarcinomas. The one with normal karyotype was evaluated as moderately differentiated. In order Io assess the effects of chromosomal changes on the proliferation activity of proslatic tumors, immunocytochemical studies on the tumor cell cultures have been performed by using the antibody Ki-67. All three tumors showed a proliferation index in the range of 18-25 %. Up to now, no correlation has been found beween Ki-67 index and the expression of EGF-R and fos. The combined approach of cytogenetics, molecular genetics and immunocytochemistry may help to delineate the pathogenetic mechanisms in prostatic cancer.

Interphase cytogenetics on brain tumors

Embed Size (px)

Citation preview

Page 1: Interphase cytogenetics on brain tumors

A b s t r a c t s 247

59

IN SITU HYBRIDIZATION WITH A CHROMOSOME 1 SPECIFIC DNA PROBE ON INTERPHASE NUCLEI FROM PROSTATE CANCER CELLS. Josee J.K0nig, Sandra de Jong, Anne Hagemeijer*, Hans Romijn and Fritz H.SchrOder. Depts. of Urology and Genetics*, Erasmus University Rotterdam, The Netherlands.

With flow cytometry half of the prostate cancers show, apart from diploid cells, considerable populations of tetraploid and/or aneuploid cells. With collagenase treatment -which is a widely used method to obtain cell suspensions from solid tumors- nearly half of the nondiploid cells is destroyed, as was shown by us earlier. When the karyotype of these same tumors was investigated, nearly all tumors were seemingly diploid with occasional nonclonal aberrations. We used detection of numerical aberrations of chromosome 1 in interphase nuclei by in situ hybridization (ISH) with the SAT III probe PUC 1.77 for further investigation of this problem. ISH was performed on nuclei obtained before and after collagenase treatment and after tissue culture and the results were compared. ISH and FCM results were congruent in showing a decline of nondiploid cells after collagenase treatment. Two tumors showed high percentages of nondiploid cells ( 23% and 59% ) in fresh preparations which had declined to 12% and 9% respectively after tissue culture. Moreover, in both tumors all metaphases seemed normal diploid. We think this result is a clear indication that selection in favor of normal diploid cells can occur in short term tissue culture of prostate epithelium. More tumors need however be investigated in this way to draw a definite conclusion. This study was supported by a grant of the Netherlands Cancer Foundation.

60 COMBINED CYTOGENETIC AND IMMUNCYTOCHEMICAL STUDY ON PROSTATE CANCER

B Wullich I, T Lindenmeir {, G. Seitz 2, Th. Zwergel 3, G Unteregger I qnst. f~r Humangenetik. Univ. des Saarlandes. D-6650 H0mburg Saar 2Ins t . f i i r P a t h o l o g i e , U n i v . d e s S a a r l a n d e s , D - 6 6 5 0 H o m b u r g / S a a r a l r r o l o g i s c h e K l i n i k , U n i v . d e s S a a r l a n d e s , D - 6 6 5 0 H o m b u r g / S a a r

S p e c i f i c c h r o m o s o m a l c h a n g e s h a v e b e e n d i s c o v e r e d in s e v e r a l h u m a n so l i d r u m o r s a n d h a v e b e e n f o u n d to be u s e f u l t o o l s in t h e d i a g n o s i s , p r o g n o s i s , a n d c l a s s i f i c a t i o n o f t h e s e d i s e a s e s . H o w e v e r , o n l y f ew c y t o g e n e t i c d a t a a r e a v a i l a b l e on p r o s t a t i c c a n c e r , a n d s p e c i f i c c h r o m o s o m a l c h a n g e s a s s o c i a t e d w i t h t h i s k i n d o f t u m o r h a v e y e t b e e n f o u n d . We s t a r t e d to p e r f o r m c y t o g e n e t i c a n a l y s e s on ce l l c u l t u r e s o f p r i m a r y p r o s t a t i c a d e n o c a r c i n o m a s a n d m e t a s t a t i c l e s i o n s , lrp to n o ~ , l o n g - t e r m c u l t u r e s w e r e s u c c e s s f u l l y e s t a b l i s h e d f rom t w e l v e t u m o r s by a p p l y i n g e n z y m a t i c d i g e s t i o n or t i s s u e e x p l a n t o f t h e r e s e c t e d t u m o r m a t e r i a l . C y l o g e n e t i c c h a r a c t e r i z a t i o n o f h i t h e r t o t h r e e t u m o r s r e v e a l e d l o s s o f t h e Y c h r o m o s o m e a s s i n g l e c l o n a l a b n o r m a l i t y in two t u m o r s . One t u m o r s h o w e d n o r m a l k a r y o t y p e . C o n c l u s i o n s a b o u t t h e s i g n i f i c a n c e o f l o s s o f t h e Y c h r o m o s o m e in d e v e l o p m e n t a n d / o r p r o g r e s s i o n o f m e t a s t a t i c c a n c e r s e e m p r e m a t u r e . R e m a r k a b l y , t h e two t u m o r s c h a r a c t e r i z e d by l o s s o f t h e Y c h r o m o s o m e w e r e h i s t o p a t h o l o g i c a l l y d i a g n o s e d a s m o d e r a t e l y d i f f e r e n t i a t e d a n d u n d i f f e r e n t i a t e d a d e n o c a r c i n o m a s . T h e o n e w i t h n o r m a l k a r y o t y p e w a s e v a l u a t e d a s m o d e r a t e l y d i f f e r e n t i a t e d . In o r d e r Io a s s e s s t h e e f f e c t s o f c h r o m o s o m a l c h a n g e s on t h e p r o l i f e r a t i o n a c t i v i t y o f p r o s l a t i c t u m o r s , i m m u n o c y t o c h e m i c a l s t u d i e s on t h e t u m o r ce l l c u l t u r e s h a v e b e e n p e r f o r m e d by u s i n g t h e a n t i b o d y K i - 6 7 . Al l t h r e e t u m o r s s h o w e d a p r o l i f e r a t i o n i n d e x in t h e r a n g e o f 1 8 - 2 5 %. Up to now, no c o r r e l a t i o n h a s b e e n f o u n d b e w e e n K i - 6 7 i n d e x a n d t h e e x p r e s s i o n o f E G F - R a n d fos . T h e c o m b i n e d a p p r o a c h o f c y t o g e n e t i c s , m o l e c u l a r g e n e t i c s a n d i m m u n o c y t o c h e m i s t r y m a y h e l p to d e l i n e a t e t h e p a t h o g e n e t i c m e c h a n i s m s in p r o s t a t i c c a n c e r .